The Netherlands Authority for the Consumer and Markets’ ("ACM") announced focus on drug...
July 21, 2021
6 min read
BioTalk is a news hub brought to you by Bird & Bird's International Life Sciences & Healthcare Group. Read more about us >
Pauline Kuipers
I am a partner in our office in The Hague where I have worked since 2001, and I am one of its founding lawyers.
Today, I lead our International Competition and EU Law Group and head our Competition Group in the Netherlands, providing our clients with wide-ranging expertise in EU & competition law, particularly in regulated sectors and on the interface between IP and competition law. I am also a member of our Tech & Comms, Media, Retail & Consumer and Life Sciences Groups.
3
Articles
0
Comments
Dutch competition authority ACM imposes EUR 20 million fine on orphan drug manufacturer Leadiant for excessive pricing
More Guidance on Pharma Settlement Agreements from the Court of Justice of the EU (ECJ)
It is clear that under certain specific circumstances, a settlement agreement between a holder of a pharmaceutical...
February 7, 2020
11 min read
Dutch competition authority ACM publishes a sector report on the impact of biosimilars on competition between TNF-alfa inhibitors
The Dutch competition authority, ACM, initiated a market study in 2018 into the effect of the introduction...
October 7, 2019
5 min read